Expression, purification, and characterization of human and rat acetyl coenzyme A carboxylase (ACC) isozymes

Acetyl coenzyme A (acetyl-CoA) carboxylase isozyme 1 (ACC1) and acetyl-CoA carboxylase isozyme 2 (ACC2) are critical for de novo fatty acid synthesis and for the regulation of beta-oxidation. Emerging evidence indicates that one or both isozymes might be therapeutic targets for the treatment of obes...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Protein expression and purification 2007-01, Vol.51 (1), p.11-21
Hauptverfasser: Cheng, Dong, Chu, Ching-Hsuen, Chen, Luping, Feder, John N, Mintier, Gabe A, Wu, Yuli, Cook, Joseph W, Harpel, Mark R, Locke, Gregory A, An, Yongmi, Tamura, James K
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 21
container_issue 1
container_start_page 11
container_title Protein expression and purification
container_volume 51
creator Cheng, Dong
Chu, Ching-Hsuen
Chen, Luping
Feder, John N
Mintier, Gabe A
Wu, Yuli
Cook, Joseph W
Harpel, Mark R
Locke, Gregory A
An, Yongmi
Tamura, James K
description Acetyl coenzyme A (acetyl-CoA) carboxylase isozyme 1 (ACC1) and acetyl-CoA carboxylase isozyme 2 (ACC2) are critical for de novo fatty acid synthesis and for the regulation of beta-oxidation. Emerging evidence indicates that one or both isozymes might be therapeutic targets for the treatment of obesity, type 2 diabetes, and dyslipidemia. One of the major obstacles in the field is the lack of readily-available source of recombinant human ACC enzymes to support systematic drug discovery efforts. Here, we describe an efficient and optimal protocol for expressing and isolating recombinant mammalian ACCs with high yield and purity. The resultant human ACC2, human ACC1, and rat ACC2 possess high specific activities, are properly biotinylated, and exhibit kinetic parameters very similar to the native ACC enzymes. We believe that the current study paves a road to a systematic approach for drug design revolving around the ACC inhibition mechanism.
doi_str_mv 10.1016/j.pep.2006.06.005
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_68363386</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68363386</sourcerecordid><originalsourceid>FETCH-LOGICAL-p139t-8083fbcb658236986402eada4b2677854e3f106e5d4e5c574c3c542948b904ce3</originalsourceid><addsrcrecordid>eNo1kEtrwzAQhHVoadK0P6CXolNpoXYl6xH5GEz6gEAv7dnI8poo-KFKNsT59U3cFAaWnW9YlkHojpKYEipfdrEDFyeEyPgkIi7QnBIuI5EmaoauQ9gRQqkk4grNqFSCH8Ec1eu98xCC7dpn7AZvK2t0P226LbHZaq9ND94eJhd3Fd4OjW4n6nWPtYF-rLHpoD2MDeAVNtoX3X6sdQD8uMqyJ2xDd2LhBl1Wug5we54L9P26_sreo83n20e22kSOsrSPFFGsKkwhhUqYTJXkJAFdal4kcrk8fg6sokSCKDkII5bcMCN4knJVpIQbYAv08HfX-e5ngNDnjQ0G6lq30A0hl4pJxpQ8Bu_PwaFooMydt432Y_7fD_sF3XVmtw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68363386</pqid></control><display><type>article</type><title>Expression, purification, and characterization of human and rat acetyl coenzyme A carboxylase (ACC) isozymes</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Cheng, Dong ; Chu, Ching-Hsuen ; Chen, Luping ; Feder, John N ; Mintier, Gabe A ; Wu, Yuli ; Cook, Joseph W ; Harpel, Mark R ; Locke, Gregory A ; An, Yongmi ; Tamura, James K</creator><creatorcontrib>Cheng, Dong ; Chu, Ching-Hsuen ; Chen, Luping ; Feder, John N ; Mintier, Gabe A ; Wu, Yuli ; Cook, Joseph W ; Harpel, Mark R ; Locke, Gregory A ; An, Yongmi ; Tamura, James K</creatorcontrib><description>Acetyl coenzyme A (acetyl-CoA) carboxylase isozyme 1 (ACC1) and acetyl-CoA carboxylase isozyme 2 (ACC2) are critical for de novo fatty acid synthesis and for the regulation of beta-oxidation. Emerging evidence indicates that one or both isozymes might be therapeutic targets for the treatment of obesity, type 2 diabetes, and dyslipidemia. One of the major obstacles in the field is the lack of readily-available source of recombinant human ACC enzymes to support systematic drug discovery efforts. Here, we describe an efficient and optimal protocol for expressing and isolating recombinant mammalian ACCs with high yield and purity. The resultant human ACC2, human ACC1, and rat ACC2 possess high specific activities, are properly biotinylated, and exhibit kinetic parameters very similar to the native ACC enzymes. We believe that the current study paves a road to a systematic approach for drug design revolving around the ACC inhibition mechanism.</description><identifier>ISSN: 1046-5928</identifier><identifier>DOI: 10.1016/j.pep.2006.06.005</identifier><identifier>PMID: 16854592</identifier><language>eng</language><publisher>United States</publisher><subject>Acetyl-CoA Carboxylase - antagonists &amp; inhibitors ; Acetyl-CoA Carboxylase - biosynthesis ; Acetyl-CoA Carboxylase - isolation &amp; purification ; Acetyl-CoA Carboxylase - metabolism ; Animals ; Baculoviridae ; Chromatography, Affinity ; Citric Acid - pharmacology ; Cloning, Molecular - methods ; Humans ; Isoenzymes - antagonists &amp; inhibitors ; Isoenzymes - biosynthesis ; Isoenzymes - isolation &amp; purification ; Isoenzymes - metabolism ; Kinetics ; Malonyl Coenzyme A - pharmacology ; Rats ; Recombinant Proteins - isolation &amp; purification ; Streptavidin - chemistry</subject><ispartof>Protein expression and purification, 2007-01, Vol.51 (1), p.11-21</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16854592$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cheng, Dong</creatorcontrib><creatorcontrib>Chu, Ching-Hsuen</creatorcontrib><creatorcontrib>Chen, Luping</creatorcontrib><creatorcontrib>Feder, John N</creatorcontrib><creatorcontrib>Mintier, Gabe A</creatorcontrib><creatorcontrib>Wu, Yuli</creatorcontrib><creatorcontrib>Cook, Joseph W</creatorcontrib><creatorcontrib>Harpel, Mark R</creatorcontrib><creatorcontrib>Locke, Gregory A</creatorcontrib><creatorcontrib>An, Yongmi</creatorcontrib><creatorcontrib>Tamura, James K</creatorcontrib><title>Expression, purification, and characterization of human and rat acetyl coenzyme A carboxylase (ACC) isozymes</title><title>Protein expression and purification</title><addtitle>Protein Expr Purif</addtitle><description>Acetyl coenzyme A (acetyl-CoA) carboxylase isozyme 1 (ACC1) and acetyl-CoA carboxylase isozyme 2 (ACC2) are critical for de novo fatty acid synthesis and for the regulation of beta-oxidation. Emerging evidence indicates that one or both isozymes might be therapeutic targets for the treatment of obesity, type 2 diabetes, and dyslipidemia. One of the major obstacles in the field is the lack of readily-available source of recombinant human ACC enzymes to support systematic drug discovery efforts. Here, we describe an efficient and optimal protocol for expressing and isolating recombinant mammalian ACCs with high yield and purity. The resultant human ACC2, human ACC1, and rat ACC2 possess high specific activities, are properly biotinylated, and exhibit kinetic parameters very similar to the native ACC enzymes. We believe that the current study paves a road to a systematic approach for drug design revolving around the ACC inhibition mechanism.</description><subject>Acetyl-CoA Carboxylase - antagonists &amp; inhibitors</subject><subject>Acetyl-CoA Carboxylase - biosynthesis</subject><subject>Acetyl-CoA Carboxylase - isolation &amp; purification</subject><subject>Acetyl-CoA Carboxylase - metabolism</subject><subject>Animals</subject><subject>Baculoviridae</subject><subject>Chromatography, Affinity</subject><subject>Citric Acid - pharmacology</subject><subject>Cloning, Molecular - methods</subject><subject>Humans</subject><subject>Isoenzymes - antagonists &amp; inhibitors</subject><subject>Isoenzymes - biosynthesis</subject><subject>Isoenzymes - isolation &amp; purification</subject><subject>Isoenzymes - metabolism</subject><subject>Kinetics</subject><subject>Malonyl Coenzyme A - pharmacology</subject><subject>Rats</subject><subject>Recombinant Proteins - isolation &amp; purification</subject><subject>Streptavidin - chemistry</subject><issn>1046-5928</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kEtrwzAQhHVoadK0P6CXolNpoXYl6xH5GEz6gEAv7dnI8poo-KFKNsT59U3cFAaWnW9YlkHojpKYEipfdrEDFyeEyPgkIi7QnBIuI5EmaoauQ9gRQqkk4grNqFSCH8Ec1eu98xCC7dpn7AZvK2t0P226LbHZaq9ND94eJhd3Fd4OjW4n6nWPtYF-rLHpoD2MDeAVNtoX3X6sdQD8uMqyJ2xDd2LhBl1Wug5we54L9P26_sreo83n20e22kSOsrSPFFGsKkwhhUqYTJXkJAFdal4kcrk8fg6sokSCKDkII5bcMCN4knJVpIQbYAv08HfX-e5ngNDnjQ0G6lq30A0hl4pJxpQ8Bu_PwaFooMydt432Y_7fD_sF3XVmtw</recordid><startdate>200701</startdate><enddate>200701</enddate><creator>Cheng, Dong</creator><creator>Chu, Ching-Hsuen</creator><creator>Chen, Luping</creator><creator>Feder, John N</creator><creator>Mintier, Gabe A</creator><creator>Wu, Yuli</creator><creator>Cook, Joseph W</creator><creator>Harpel, Mark R</creator><creator>Locke, Gregory A</creator><creator>An, Yongmi</creator><creator>Tamura, James K</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200701</creationdate><title>Expression, purification, and characterization of human and rat acetyl coenzyme A carboxylase (ACC) isozymes</title><author>Cheng, Dong ; Chu, Ching-Hsuen ; Chen, Luping ; Feder, John N ; Mintier, Gabe A ; Wu, Yuli ; Cook, Joseph W ; Harpel, Mark R ; Locke, Gregory A ; An, Yongmi ; Tamura, James K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p139t-8083fbcb658236986402eada4b2677854e3f106e5d4e5c574c3c542948b904ce3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Acetyl-CoA Carboxylase - antagonists &amp; inhibitors</topic><topic>Acetyl-CoA Carboxylase - biosynthesis</topic><topic>Acetyl-CoA Carboxylase - isolation &amp; purification</topic><topic>Acetyl-CoA Carboxylase - metabolism</topic><topic>Animals</topic><topic>Baculoviridae</topic><topic>Chromatography, Affinity</topic><topic>Citric Acid - pharmacology</topic><topic>Cloning, Molecular - methods</topic><topic>Humans</topic><topic>Isoenzymes - antagonists &amp; inhibitors</topic><topic>Isoenzymes - biosynthesis</topic><topic>Isoenzymes - isolation &amp; purification</topic><topic>Isoenzymes - metabolism</topic><topic>Kinetics</topic><topic>Malonyl Coenzyme A - pharmacology</topic><topic>Rats</topic><topic>Recombinant Proteins - isolation &amp; purification</topic><topic>Streptavidin - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cheng, Dong</creatorcontrib><creatorcontrib>Chu, Ching-Hsuen</creatorcontrib><creatorcontrib>Chen, Luping</creatorcontrib><creatorcontrib>Feder, John N</creatorcontrib><creatorcontrib>Mintier, Gabe A</creatorcontrib><creatorcontrib>Wu, Yuli</creatorcontrib><creatorcontrib>Cook, Joseph W</creatorcontrib><creatorcontrib>Harpel, Mark R</creatorcontrib><creatorcontrib>Locke, Gregory A</creatorcontrib><creatorcontrib>An, Yongmi</creatorcontrib><creatorcontrib>Tamura, James K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Protein expression and purification</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cheng, Dong</au><au>Chu, Ching-Hsuen</au><au>Chen, Luping</au><au>Feder, John N</au><au>Mintier, Gabe A</au><au>Wu, Yuli</au><au>Cook, Joseph W</au><au>Harpel, Mark R</au><au>Locke, Gregory A</au><au>An, Yongmi</au><au>Tamura, James K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expression, purification, and characterization of human and rat acetyl coenzyme A carboxylase (ACC) isozymes</atitle><jtitle>Protein expression and purification</jtitle><addtitle>Protein Expr Purif</addtitle><date>2007-01</date><risdate>2007</risdate><volume>51</volume><issue>1</issue><spage>11</spage><epage>21</epage><pages>11-21</pages><issn>1046-5928</issn><abstract>Acetyl coenzyme A (acetyl-CoA) carboxylase isozyme 1 (ACC1) and acetyl-CoA carboxylase isozyme 2 (ACC2) are critical for de novo fatty acid synthesis and for the regulation of beta-oxidation. Emerging evidence indicates that one or both isozymes might be therapeutic targets for the treatment of obesity, type 2 diabetes, and dyslipidemia. One of the major obstacles in the field is the lack of readily-available source of recombinant human ACC enzymes to support systematic drug discovery efforts. Here, we describe an efficient and optimal protocol for expressing and isolating recombinant mammalian ACCs with high yield and purity. The resultant human ACC2, human ACC1, and rat ACC2 possess high specific activities, are properly biotinylated, and exhibit kinetic parameters very similar to the native ACC enzymes. We believe that the current study paves a road to a systematic approach for drug design revolving around the ACC inhibition mechanism.</abstract><cop>United States</cop><pmid>16854592</pmid><doi>10.1016/j.pep.2006.06.005</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1046-5928
ispartof Protein expression and purification, 2007-01, Vol.51 (1), p.11-21
issn 1046-5928
language eng
recordid cdi_proquest_miscellaneous_68363386
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Acetyl-CoA Carboxylase - antagonists & inhibitors
Acetyl-CoA Carboxylase - biosynthesis
Acetyl-CoA Carboxylase - isolation & purification
Acetyl-CoA Carboxylase - metabolism
Animals
Baculoviridae
Chromatography, Affinity
Citric Acid - pharmacology
Cloning, Molecular - methods
Humans
Isoenzymes - antagonists & inhibitors
Isoenzymes - biosynthesis
Isoenzymes - isolation & purification
Isoenzymes - metabolism
Kinetics
Malonyl Coenzyme A - pharmacology
Rats
Recombinant Proteins - isolation & purification
Streptavidin - chemistry
title Expression, purification, and characterization of human and rat acetyl coenzyme A carboxylase (ACC) isozymes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T08%3A33%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expression,%20purification,%20and%20characterization%20of%20human%20and%20rat%20acetyl%20coenzyme%20A%20carboxylase%20(ACC)%20isozymes&rft.jtitle=Protein%20expression%20and%20purification&rft.au=Cheng,%20Dong&rft.date=2007-01&rft.volume=51&rft.issue=1&rft.spage=11&rft.epage=21&rft.pages=11-21&rft.issn=1046-5928&rft_id=info:doi/10.1016/j.pep.2006.06.005&rft_dat=%3Cproquest_pubme%3E68363386%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68363386&rft_id=info:pmid/16854592&rfr_iscdi=true